Valproate bismuth is a pharmaceutical compound in which bismuth is complexed with valproic acid (valproate) and is mainly available in Canada as an ingredient in the over-the-counter medication Neo-Laryngobis, that is used for symptomatic relief of laryngitis and other inflammatory conditions of the throat. The formulation aims to deliver local anti-inflammatory and antimicrobial effects, with the bismuth moiety providing topical action in the throat area, while the valproate part acts mainly as a counter-ion to improve the compound’s absorption and stability when administered (especially in suppository form). The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bismuth dipropylacetate and Bismuth 2-propylvalerate. Its PubChem CID is 20835964.
Valproate bismuth
| CAS No | 60364-28-5 |
|---|---|
| Molecular Formula | C24H45BiO6 |
| Molecular Weight | 638.6 g/mol |
| Synonyms | bismuth tris(2-propylpentanoate) |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Valproate bismuth is a pharmaceutical compound in which bismuth is complexed with valproic acid (valproate) and is mainly available in Canada as an ingredient in the over-the-counter medication Neo-Laryngobis, that is used for symptomatic relief of laryngitis and other inflammatory conditions of the throat.
The listed CAS number is 60364-28-5.
The listed molecular formula is C24H45BiO6.
The listed molecular weight is 638.6 g/mol.
bismuth tris(2-propylpentanoate).
The source lists Bismuth dipropylacetate and Bismuth 2-propylvalerate.